These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23818800)

  • 21. Taxes and Subsidies for Improving Diet and Population Health in Australia: A Cost-Effectiveness Modelling Study.
    Cobiac LJ; Tam K; Veerman L; Blakely T
    PLoS Med; 2017 Feb; 14(2):e1002232. PubMed ID: 28196089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Economic evaluation of therapies for patients suffering from relapsed-refractory multiple myeloma in Greece.
    Fragoulakis V; Kastritis E; Psaltopoulou T; Maniadakis N
    Cancer Manag Res; 2013; 5():37-48. PubMed ID: 23596356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A cost-effectiveness analysis of freeze-only or fresh embryo transfer in IVF of non-PCOS women.
    Le KD; Vuong LN; Ho TM; Dang VQ; Pham TD; Pham CT; Norman RJ; Mol BWJ
    Hum Reprod; 2018 Oct; 33(10):1907-1914. PubMed ID: 30239784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A retrospective evaluation of prognosis and cost-effectiveness of IVF in poor responders according to the Bologna criteria.
    Busnelli A; Papaleo E; Del Prato D; La Vecchia I; Iachini E; Paffoni A; Candiani M; Somigliana E
    Hum Reprod; 2015 Feb; 30(2):315-22. PubMed ID: 25432927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fiscal Impact of Smoking Cessation in Thailand: A Government Perspective Cost-Benefit Analysis.
    Connolly MP; Kotsopoulos N; Suthipinijtham P; Rungruanghiranya S
    Asia Pac J Public Health; 2018 May; 30(4):342-350. PubMed ID: 29667916
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The fiscal consequences of ADHD in Germany: a quantitative analysis based on differences in educational attainment and lifetime earnings.
    Kotsopoulos N; Connolly MP; Sobanski E; Postma MJ
    J Ment Health Policy Econ; 2013 Mar; 16(1):27-33. PubMed ID: 23676413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The fiscal consequences of public health investments in disease-modifying therapies for the treatment of multiple sclerosis in Sweden.
    Kotsopoulos N; Connolly MP; Dort T; Kavaliunas A
    J Med Econ; 2020 Aug; 23(8):831-837. PubMed ID: 32400258
    [No Abstract]   [Full Text] [Related]  

  • 28. Cost-effectiveness of 'immediate IVF' versus 'delayed IVF': a prospective study.
    Eijkemans MJC; Kersten FAM; Lintsen AME; Hunault CC; Bouwmans CAM; Roijen LH; Habbema JDF; Braat DDM
    Hum Reprod; 2017 May; 32(5):999-1008. PubMed ID: 28204519
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost-effectiveness of embryo transfer strategies: a decision analytic model using long-term costs and consequences of singletons and multiples born as a consequence of IVF.
    van Heesch MM; van Asselt AD; Evers JL; van der Hoeven MA; Dumoulin JC; van Beijsterveldt CE; Bonsel GJ; Dykgraaf RH; van Goudoever JB; Koopman-Esseboom C; Nelen WL; Steiner K; Tamminga P; Tonch N; Torrance HL; Dirksen CD
    Hum Reprod; 2016 Nov; 31(11):2527-2540. PubMed ID: 27907897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation.
    Kotsopoulos N; Connolly MP; Postma MJ; Hutubessy RC
    Vaccine; 2013 Nov; 31(46):5430-4. PubMed ID: 24055088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimating the Societal Benefits of THA After Accounting for Work Status and Productivity: A Markov Model Approach.
    Koenig L; Zhang Q; Austin MS; Demiralp B; Fehring TK; Feng C; Mather RC; Nguyen JT; Saavoss A; Springer BD; Yates AJ
    Clin Orthop Relat Res; 2016 Dec; 474(12):2645-2654. PubMed ID: 27699631
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Estimating the broader fiscal consequences of acute hepatic porphyria (AHP) with recurrent attacks in Belgium using a public economic analytic framework.
    Connolly MP; Kotsopoulos N; Vermeersch S; Patris J; Cassiman D
    Orphanet J Rare Dis; 2021 Aug; 16(1):346. PubMed ID: 34348763
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative cost-benefit analysis of tele-homecare for community-dwelling elderly in Japan: Non-Government versus Government Supported Funding Models.
    Akiyama M; Abraham C
    Int J Med Inform; 2017 Aug; 104():1-9. PubMed ID: 28599810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling the fiscal costs and benefits of alternative treatment strategies in the United Kingdom for chronic hepatitis C.
    Connolly MP; Kotsopoulos N; Ustianowski A
    J Med Econ; 2018 Jan; 21(1):19-26. PubMed ID: 28830254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tax credits, insurance, and in vitro fertilization in the U.S. military health care system.
    Wu M; Henne M; Propst A
    Mil Med; 2012 Jun; 177(6):745-7. PubMed ID: 22730853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness analysis of lifestyle intervention in obese infertile women.
    van Oers AM; Mutsaerts MAQ; Burggraaff JM; Kuchenbecker WKH; Perquin DAM; Koks CAM; van Golde R; Kaaijk EM; Schierbeek JM; Klijn NF; van Kasteren YM; Land JA; Mol BWJ; Hoek A; Groen H;
    Hum Reprod; 2017 Jul; 32(7):1418-1426. PubMed ID: 28486704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost effectiveness of in vitro fertilisation and preimplantation genetic testing to prevent transmission of BRCA1/2 mutations.
    Lipton JH; Zargar M; Warner E; Greenblatt EE; Lee E; Chan KKW; Wong WWL
    Hum Reprod; 2020 Feb; 35(2):434-445. PubMed ID: 32099994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Projected Impact of Mexico's Sugar-Sweetened Beverage Tax Policy on Diabetes and Cardiovascular Disease: A Modeling Study.
    Sánchez-Romero LM; Penko J; Coxson PG; Fernández A; Mason A; Moran AE; Ávila-Burgos L; Odden M; Barquera S; Bibbins-Domingo K
    PLoS Med; 2016 Nov; 13(11):e1002158. PubMed ID: 27802278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of the first in vitro fertilization cycle for unexplained infertility: a cost-effectiveness analysis of split in vitro fertilization-intracytoplasmic sperm injection.
    Vitek WS; Galárraga O; Klatsky PC; Robins JC; Carson SA; Blazar AS
    Fertil Steril; 2013 Nov; 100(5):1381-8. PubMed ID: 23876534
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International collaborative study of intracytoplasmic sperm injection-conceived, in vitro fertilization-conceived, and naturally conceived 5-year-old child outcomes: cognitive and motor assessments.
    Ponjaert-Kristoffersen I; Bonduelle M; Barnes J; Nekkebroeck J; Loft A; Wennerholm UB; Tarlatzis BC; Peters C; Hagberg BS; Berner A; Sutcliffe AG
    Pediatrics; 2005 Mar; 115(3):e283-9. PubMed ID: 15741353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.